Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CTSL | P07711 | 1/20 | 0.49 |
| ▸ | CTSB | P07858 | 1/20 | 0.49 |
| ▸ | CTSK | P43235 | 1/20 | 0.49 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.45 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.45 |
| ▸ | TP53 | P04637 | 2/20 | 0.43 |
| ▸ | CA12 | O43570 | 1/20 | 0.43 |
| ▸ | CA1 | P00915 | 1/20 | 0.43 |
| ▸ | MMP2 | P08253 | 1/20 | 0.43 |
| ▸ | NPSR1 | Q6W5P4 | 2/20 | 0.43 |
| ▸ | MEN1 | O00255 | 3/20 | 0.43 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.43 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.43 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.43 |
| ▸ | CYP2C9 | P11712 | 2/20 | 0.43 |
| ▸ | MAPT | P10636 | 2/20 | 0.43 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.43 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.43 |
| ▸ | GAA | P10253 | 1/20 | 0.43 |
| ▸ | XBP1 | P17861 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL17848962 | 0.84 | ALDH1A1 (0.41) | CTSLCTSBCTSKSMN1; SMN2KDM4E | |
| SCHEMBL11206190 | 0.79 | NPSR1 (0.60) | CTSLCTSBCTSKSMN1; SMN2KDM4E | |
| SCHEMBL11206192 | 0.79 | NPSR1 (0.60) | CTSLCTSBCTSKSMN1; SMN2KDM4E | |
| SCHEMBL3468963 | 0.77 | CTSL (0.53) | CTSLCTSBCTSKSMN1; SMN2KDM4E | |
| SCHEMBL2473494 | 0.77 | CTSL (0.53) | CTSLCTSBCTSKSMN1; SMN2KDM4E | |
| SCHEMBL17848980 | 0.77 | ALDH1A1 (0.35) | MAPTGAAALDH1A1 | |
| SCHEMBL17849026 | 0.76 | MAPT (0.36) | CTSLCTSBCTSKSMN1; SMN2CA12 | |
| SCHEMBL17848983 | 0.76 | MEN1 (0.35) | SMN1; SMN2KDM4EMEN1KMT2AMAPT | |
| SCHEMBL17849020 | 0.75 | KMT2A (0.38) | SMN1; SMN2KDM4ECA12CA1MMP2 | |
| Methyl Alcohol SCHEMBL17848974 | 0.75 | MEN1 (0.35) | SMN1; SMN2KDM4EMEN1KMT2AMAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 91 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20070202203-A1 | ANTI-AGEING COMPOSITION | L'OREAL (FR) | 2007-08-30 | — | — | US | claimed |
| EP-1889642-B1 | Cosmetic compositions combining a C-glycoside derivative and a N-acylaminoamide derivative | OREAL (FR) | 2019-05-08 | — | — | EP | disclosed |
| US-10173080-B2 | Dehydroascorbic acid or monomeric, polymeric or isomeric derivative thereof and an amine for artificially coloring the skin | L'OREAL (FR) | 2019-01-08 | — | — | US | disclosed |
| EP-2753300-B1 | COMBINATION OF CARRAGEENAN AND C-GLYCOSIDE AND USES THEREOF | OREAL (FR) | 2018-12-12 | — | — | EP | disclosed |
| US-9974984-B2 | Combination of monosaccharides with antioxidants and use thereof | L'OREAL (FR) | 2018-05-22 | — | — | US | disclosed |
| EP-2204163-B1 | Combination of monosaccharides and ascorbic acid and its use in cosmetic | L'ORÉAL (FR) | 2017-11-29 | — | — | EP | disclosed |
| EP-2223680-B1 | Combination of monosaccharides and exfoliating agents and its cosmetic use | L'ORÉAL (FR) | 2017-10-18 | — | — | EP | disclosed |
| US-9643032-B2 | Application of dehydroascorbic acid or derivatives/isomers thereof for artificially coloring the skin | L'OREAL (FR) | 2017-05-09 | — | — | US | disclosed |
| EP-1837013-B1 | Composition comprising hydroxyapatite and a calcium salt for reinforcing the barrier function of the skin and/or semi-mucus membranes. | L'ORÉAL (FR) | 2017-04-19 | — | — | EP | disclosed |
| EP-2234674-B1 | FLUID OIL-IN-WATER SUNSCREEN EMULSIONS CONTAINING A SELECTED GEMINI SURFACTANT AND A CROSSLINKED COPOLYMER OF METHACRYLIC ACID AND OF ETHYL ACRYLATE | L'ORÉAL (FR) | 2017-03-29 | — | — | EP | disclosed |
| EP-1897526-A1 | Oil in water cosmetic emulsion | L'Oréal (FR) | 2008-03-12 | — | — | EP | disclosed |
| US-20080050333-A1 | OIL-IN-WATER DISPERSION | L'OREAL (FR) | 2008-02-28 | — | — | US | disclosed |
| EP-1889642-A2 | Cosmetic compositions combining a C-glycoside derivative and a N-acylaminoamide derivative | L'OREAL (FR) | 2008-02-20 | — | — | EP | disclosed |
| US-20080014230-A1 | Cosmetic compositions combining a C-glycoside derivative and an N-acylamino amide derivative | L'OREAL (FR) | 2008-01-17 | — | — | US | disclosed |
| US-20080008673-A1 | Compositions comprising at least one C-glycoside derivative | L'OREAL S.A. (FR) | 2008-01-10 | — | — | US | disclosed |
| WO-2008004164-A2 | COSMETIC AND/OR DERMATOLOGICAL COMPOSITION COMBINING A C-GLYCOSIDE DERIVATIVE AND A DESQUAMATING AGENT | L'OREAL (FR) | 2008-01-10 | — | — | WO | disclosed |
| US-20070248633-A1 | COMPOSITIONS CONTAINING A HYDROXYLATED DIPHENYLMETHANE COMPOUND, METHODS OF USE | L'OREAL (FR) | 2007-10-25 | — | — | US | disclosed |
| EP-1847247-A1 | Compositions comprising a hydroxylated diphenyl-methane derivative | L'OREAL (FR) | 2007-10-24 | — | — | EP | disclosed |
| EP-1837013-A1 | Composition comprising hydroxyapatite and a calcium salt for reinforcing the barrier function of the skin and/or semi-mucus membranes. | L'OREAL (FR) | 2007-09-26 | — | — | EP | disclosed |
| US-20070202203-A1 | ANTI-AGEING COMPOSITION | L'OREAL (FR) | 2007-08-30 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (6 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080008673-A1 | Compositions comprising at least one C-glycoside derivative | DSG1, TYR, CUTA | CTSL 1407/4885CTSB 723/4885CTSK 570/4885 |
| US-20080050333-A1 | OIL-IN-WATER DISPERSION | DEGS1, ABHD6, MGLL | CTSL 4869/4885CTSB 4878/4885CTSK 4875/4885 |
| US-20070248633-A1 | COMPOSITIONS CONTAINING A HYDROXYLATED DIPHENYLMETHANE COMPOUND, METHODS OF USE | DPM1, CYP8B1, CUTA | CTSL 4412/4885CTSB 3416/4885CTSK 3453/4885 |
| US-20080014230-A1 | Cosmetic compositions combining a C-glycoside derivative and an N-acylamino amide derivative | AMDHD2, B3GNT2, CUTA | CTSL 1886/4885CTSB 984/4885CTSK 1004/4885 |
| US-10173080-B2 | Dehydroascorbic acid or monomeric, polymeric or isomeric derivative thereof and an amine for artificially coloring the skin | OXER1, AKR1B10, RBP1 | CTSL 4100/4885CTSB 3021/4885CTSK 3525/4885 |
| US-20070202203-A1 | ANTI-AGEING COMPOSITION | GLA, CUTA, CD44 | CTSL 2864/4885CTSB 1507/4885CTSK 1560/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.